Search results for

Xerox has lost its three-year battle with 3Com over patent infringement of its "Unistroke" software on the basis that there was "no genuine issue to any material fact". The decision on June 8, in Rochester, New York, by US district judge Michael A Telesca, destroys Xerox's hopes of receiving royalties on each Palm handheld organiser sold.

Oscar Gonzalez-Gonzalez and Hector Chagoya, of Mexico City's Becerril, Coca & Becerril, SC, examine the Mexican regime for protecting pharmaceutical products against generics

Patent protection in Russia defended

The Trade Mark Act which came into force on March 1 2000 has brought some changes to the Trade Mark Law of Finland. The new Trade Mark Act has brought the Finnish Trade Mark Law into line with the Trade Mark Treaty (TLT).

A recent Supreme Court decision in Japan will speed up patent litigation but innocent potential defendants should act early to avoid costly court battles. John A Tessensohn and Shusaku Yamamoto explain why

Remco EP de Ranitz and Michiel Rijsdijk of Arnold & Siedsma in The Hague, provide an overview of the latest developments in patent litigation in the Netherlands

In the light of the State Street decision in the US, Rainer Viktor, of Vossius & Partner in Munich, asks to what extent software and business-methods are patentable in Europe

Patent owners should be aware of the limitations regarding amending patent claims in the former Soviet Union. Antti Papula, of Nevinpat in Helsinki, examines the rules in Russia and the CIS

Michel Jolicoeur and Alessandra Romeo, of Racheli & C in Milan, provide a guide to enforcement strategies against counterfeiters

According to German case law, patents directed to the use of a substance or a device for a certain purpose may confer protection which goes beyond the actual application of the method of use. If the product involved shows an "obvious orientation" or "apparent adaptation" towards the protected use, a use claim protects a patentee essentially in the same manner as a product claim directed to that product. This adaptation of the product includes acts as formulation, ready-for-use packaging together with instructions, dosage (for medical substances), or similar preparations towards the protected use.